CHICAGO, Feb. 27 /PRNewswire-FirstCall/ -- Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, is holding a conference call for institutional investors including portfolio managers at mutual funds, hedge funds, pensions, and endowments. The topic of the call is "The Top 15 Biotech Acquisition Targets" and it will be held at 11 a.m. EST, 10 a.m. CST on Wednesday, March 4.
Damien Conover, CFA, Morningstar's equity strategist for the healthcare sector and the Morningstar Healthcare Observer institutional newsletter, will share the results of analysis conducted by Morningstar's team of 12 healthcare analysts on the 63 biotech companies they cover. The team ranked each company by its likelihood of being acquired based upon a methodology that weighed drug portfolio strength, profit-boosting power, collaborative fit, financial health, and recent stock performance.
Conover will be joined on the call by biotech analyst Karen Andersen.
Institutional investors: To obtain dial-in instructions, please RSVP with your name and company name to Heather Brilliant, Morningstar's Director of Stock Analysis, at firstname.lastname@example.org.
Press registration: To obtain dial-in instructions, please RSVP to Courtney Goethals Dobrow at email@example.com.
About Morningstar, Inc.
Morningstar, Inc. is a leading provider of independent investment research
in North America, Europe, Australia, and Asia. The company offers
|SOURCE Morningstar, Inc.|
Copyright©2009 PR Newswire.
All rights reserved